OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2008
(3)
2023
(1)
2017
(1)
2016
(1)
2015
(1)
2012
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Not available
S-EPMC10344437
|
biostudies-literature
Cite
Smoking cessation and outcome after ischemic stroke or TIA.
Not available
S-EPMC5644463
|
biostudies-literature
Cite
Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.
Not available
S-EPMC4439299
|
biostudies-literature
Cite
Warfarin and aspirin in patients with heart failure and sinus rhythm.
Not available
S-EPMC3723382
|
biostudies-literature
Cite
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Not available
S-EPMC4887756
|
biostudies-literature
Cite
Telmisartan to prevent recurrent stroke and cardiovascular events.
Not available
S-EPMC2714258
|
biostudies-literature
Cite
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.
Not available
S-EPMC2772657
|
biostudies-literature
Cite
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Not available
S-EPMC2714259
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets